Kim Popovits, Hakan Sakul

The Personalized Medicine Coalition has elected two new board members, Genomic Health CEO Kim Popovits and Hakan Sakul, head of diagnostics at Pfizer. Popovits and Sakul are joining PMC's board as the terms for two current members — Felix Frueh of Human Longevity and Jeffrey Cossman, formerly of United States Diagnostic Standards — expire.